Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

health technology assessments

This page shows the latest health technology assessments news and features for those working in and with pharma, biotech and healthcare.

Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant

Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant

The results from DAYLIGHT, which Astellas said will support health technology assessments for reimbursement negotiations, show that oral dosing with fezolinetant at a dose of 45mg per day achieved a statistically

Latest news

  • Promoting off-label use: where to draw the line? Promoting off-label use: where to draw the line?

    public health risk, compassionate use for groups of patients or for individual patients on a named basis. ... The approach put forward by the report undermines both the EU regulatory system for approving medicines and the national pricing and

  • Patent changes 'could boost UK as research location' Patent changes 'could boost UK as research location'

    and health technology assessments for all drugs (not just generics and biosimilars) and all applications for marketing approval anywhere in the world," according to Mewburn Ellis.

  • The search for a cancer cure demands collaboration - J&J research head

    science and technology staff. ... Driving J&J's approach is the changing economic environment, which Stoffels said has created a very high “innovation threshold” in pharma, with the market - including health technology assessments (HTA) - expecting

  • IQWiG, MRC and Cochrane back trial transparency campaign IQWiG, MRC and Cochrane back trial transparency campaign

    of all clinical trials and all information on methods and results of these trials is essential for us to provide unbiased and meaningful assessments. ... Health technology assessment should be based on a full evidence base and thus requires registration

  • Real-world data to assess value

    Against current aspirations to develop an outcomes-based health service, RW data is essential. ... Currently, decisions are largely based on traditional RCTs that have been geared towards product approval, launch and health technology assessments.

More from news
Approximately 1 fully matching, plus 27 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...

Quick links